DYN
Price
$8.76
Change
-$0.18 (-2.01%)
Updated
Jul 3 closing price
Capitalization
1.24B
27 days until earnings call
OKYO
Price
$2.91
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
108.9M
32 days until earnings call
Interact to see
Advertisement

DYN vs OKYO

Header iconDYN vs OKYO Comparison
Open Charts DYN vs OKYOBanner chart's image
Dyne Therapeutics
Price$8.76
Change-$0.18 (-2.01%)
Volume$1.99M
Capitalization1.24B
OKYO Pharma
Price$2.91
Change-$0.00 (-0.00%)
Volume$3
Capitalization108.9M
DYN vs OKYO Comparison Chart in %
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYN vs. OKYO commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a StrongBuy and OKYO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (DYN: $8.76 vs. OKYO: $2.78)
Brand notoriety: DYN and OKYO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 72% vs. OKYO: 43%
Market capitalization -- DYN: $1.24B vs. OKYO: $108.9M
DYN [@Biotechnology] is valued at $1.24B. OKYO’s [@Biotechnology] market capitalization is $108.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileOKYO’s FA Score has 0 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • OKYO’s FA Score: 0 green, 5 red.
According to our system of comparison, both DYN and OKYO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 5 TA indicator(s) are bullish while OKYO’s TA Score has 4 bullish TA indicator(s).

  • DYN’s TA Score: 5 bullish, 5 bearish.
  • OKYO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both DYN and OKYO are a good buy in the short-term.

Price Growth

DYN (@Biotechnology) experienced а -12.84% price change this week, while OKYO (@Biotechnology) price change was +14.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

DYN is expected to report earnings on Jul 31, 2025.

OKYO is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($1.24B) has a higher market cap than OKYO($109M). OKYO YTD gains are higher at: 141.760 vs. DYN (-62.818).
DYNOKYODYN / OKYO
Capitalization1.24B109M1,138%
EBITDA-395.31MN/A-
Gain YTD-62.818141.760-44%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash677MN/A-
Total Debt23.3MN/A-
TECHNICAL ANALYSIS
Technical Analysis
DYNOKYO
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
56%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
56%
Advances
ODDS (%)
Bullish Trend 28 days ago
85%
Bullish Trend 2 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 17 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BVSIX17.620.05
+0.28%
Baywood Socially Responsible Instl
RINCX18.30N/A
N/A
Victory RS Science and Technology C
WASYX23.39N/A
N/A
Macquarie Asset Strategy Fund Cl Y
JATAX67.29N/A
N/A
Janus Henderson Glb Tech and Innovt A
JEEDX16.77N/A
N/A
JHancock Infrastructure R6

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
-2.01%
RNA - DYN
56%
Loosely correlated
-0.65%
CRNX - DYN
55%
Loosely correlated
+1.22%
XNCR - DYN
52%
Loosely correlated
+1.45%
SYRE - DYN
51%
Loosely correlated
+1.68%
RVMD - DYN
49%
Loosely correlated
+1.83%
More

OKYO and

Correlation & Price change

A.I.dvisor tells us that OKYO and DYN have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OKYO and DYN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OKYO
1D Price
Change %
OKYO100%
-4.47%
DYN - OKYO
28%
Poorly correlated
-2.01%
XRTX - OKYO
27%
Poorly correlated
-9.99%
VXRT - OKYO
26%
Poorly correlated
-2.51%
NXTC - OKYO
26%
Poorly correlated
+1.75%
MRNA - OKYO
26%
Poorly correlated
+0.69%
More